Insightful Corporation Releases Insightful Clinical Graphics Version 1.1
01 Juillet 2008 - 3:00PM
Business Wire
Insightful Corporation (NASDAQ:IFUL), a leading provider of
predictive analytics and reporting solutions, announced today the
release and immediate availability of version 1.1 of Insightful
Clinical Graphics (iCG), a product for defining and repurposing
statistical graphics across all functional areas in drug discovery,
development and marketing. iCG 1.1 features new graph types and an
improved user experience. Pharmaceutical companies currently
starting projects with iCG 1.1 include H.�Lundbeck A/S in Denmark.
�Many global pharmaceutical companies are looking to integrate
graphics into their clinical trials process, making iCG one of our
most significant life science solutions to date,� said Jeff Coombs,
CEO of Insightful. �With iCG, customers save time and resources,
perform better scientific analysis and interpretation, and
communicate more effectively with internal and external
stakeholders.� With input from multiple life sciences companies,
Insightful designed iCG to simplify the creation and re-use of
statistical graphics and elimination of redundant work processes.
From discovery, pre-clinical and clinical trials, through marketing
and epidemiology, iCG enables scientific data to be presented as
actionable information in clinical study reports, regulatory
submissions, publications and presentations. iCG helps optimize the
deployment of expensive statistical programming resources by
allowing non-programming statisticians, clinicians and medical
writers to apply customizable graph templates to study data and to
change a graph style, without compromising the data or the results
displayed. Key Features and Enhancements iCG 1.1 contains a number
of significant enhancements: Expanded 2D graph palette, including
bubble, delta, cumulative incidence and double dot plots Support
for 3D graph types, including contour and image plots Added plug-in
customization of graph palette, graph metadata and workflow
Improved user experience and system performance Reduced dependence
on Information Technology staff Insightful Life Sciences Solutions
Provide the Knowledge to Act� Insightful provides life sciences
organizations with the knowledge they need to drive faster, better
decisions, with specialized analytics, graphics and reporting.
Insightful offers software and service solutions in statistical
graphics, PK/PD analysis and reporting, clinical data review,
clinical trial design, and safety data analysis. These solutions
are designed to integrate with existing data management and
workflow systems in exploratory and validated environments, to
speed the analysis and reporting processes and increase the
likelihood of discerning safety and efficacy signals earlier in the
drug development process, thus decreasing customers� product
development costs and time to market. ABOUT INSIGHTFUL Insightful
Corporation (NASDAQ:IFUL) is a provider of predictive analytics and
reporting solutions. Insightful products S-PLUS�, Insightful Miner�
and S-PLUS� Enterprise Server allow companies to perform
sophisticated statistical data analysis and data mining and create
high-quality graphics and reports. Insightful has been delivering
industry-leading, high-ROI solutions to thousands of companies in
financial services, life sciences, telecommunications, and
manufacturing, plus government and research institutions, for 20
years. Headquartered in Seattle, Insightful has offices in New
York, North Carolina, Switzerland, the United Kingdom, France and
Hong Kong, with distributors around the world. For more
information, visit www.insightful.com, email info@insightful.com or
call 1-800-569-0123. Note to Investors � Forward Looking Statements
This press release contains forward-looking statements, including
statements about the potential performance and advantages of iCG
and other life sciences solutions and their potential value to
customers. Forward-looking statements are based on the judgment and
opinions of management at the time the statements are made.
Inaccurate assumptions and known and unknown risks and
uncertainties can affect the accuracy of forward-looking
statements. Actual results could differ materially from those
expressed or implied by the forward-looking statements for a number
of reasons, including, without limitation, the risk that our
products do not perform as designed and expected and the risk that
our products do not achieve market acceptance. More detailed
information regarding these and other factors that could affect
actual results is set forth in our filings with the Securities and
Exchange Commission, including our most recent report on Form
10-KSB. You should not unduly rely on these forward-looking
statements, which apply only as of the date of this release. We
undertake no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date of this release or to reflect the occurrence of
anticipated events.
Insightful (NASDAQ:IFUL)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Insightful (NASDAQ:IFUL)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024